2008
DOI: 10.1097/rhu.0b013e3181772cca
|View full text |Cite
|
Sign up to set email alerts
|

The Use of Procalcitonin Determinations in Evaluation of Systemic Lupus Erythematosus

Abstract: This study demonstrates that there is no association between the activity of SLE and PCT levels. The utility of the PCT resides is in raising suspicion of a concurrent bacterial or mycotic infection in the evaluation of patients with active autoimmune diseases.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

4
15
0

Year Published

2010
2010
2022
2022

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 39 publications
(19 citation statements)
references
References 23 publications
4
15
0
Order By: Relevance
“…However, the usefulness of procalcitonin to identify systemic bacterial infections in patients with SLE remains controversial. Although several studies have examined procalcitonin in SLE patients with infections, those studies have been limited by small numbers of patients with infection, analysis of multiple serum samples, variability of patient characteristics, or with the inclusion of patients with other systemic autoimmune disease 16,17,25,28,29,30 . One study demonstrated that SLE patients with bacterial or fungal infections (n = 9) had significantly higher procalcitonin levels than those with viral infections (n = 3) or lupus flares (n = 7) and a normal control group (n = 11) 16 .…”
Section: Journal Of Rheumatologymentioning
confidence: 99%
“…However, the usefulness of procalcitonin to identify systemic bacterial infections in patients with SLE remains controversial. Although several studies have examined procalcitonin in SLE patients with infections, those studies have been limited by small numbers of patients with infection, analysis of multiple serum samples, variability of patient characteristics, or with the inclusion of patients with other systemic autoimmune disease 16,17,25,28,29,30 . One study demonstrated that SLE patients with bacterial or fungal infections (n = 9) had significantly higher procalcitonin levels than those with viral infections (n = 3) or lupus flares (n = 7) and a normal control group (n = 11) 16 .…”
Section: Journal Of Rheumatologymentioning
confidence: 99%
“…A mild increase of PCT values could be observed in some patients with an inflammatory, non-infectious condition. 17 The general departure point in the majority of earlier studies, that focus on circulating levels of biomarkers in febrile patients, is infection. In this review we describe, for the first time, the diagnostic applicability of traditional laboratory markers, procalcitonin and other promising biomarkers, taking non-infectious febrile diseases as a departure point.…”
Section: Introductionmentioning
confidence: 99%
“…Serum procalcitonin levels are elevated in bacterial CAPs, but not in SLE or H1N1 pneumonia. [23][24][25] The pleural effusions in SLE have elevated ANA titers, unlike bacterial pleural effusions. 26 In contrast to patients with SLE pneumonitis, patients with H1N1 pneumonia manifest partly interstitial infiltrates and are hypoxemic.…”
Section: Discussionmentioning
confidence: 99%